Robert Chang is co-founder, president, and CEO of MVRx. A medical device entrepreneur and innovator, Robert developed and championed the company’s technology now known as the ARTO System from its beginnings to the current late-stage global clinical trials. Rob is a hands-on manager and enjoys working with teams to achieve unimaginable objectives.

Rob has more than 30 years of executive and development experience, predominantly in structural heart therapies. Most recently he was an Executive Vice President and Chief Technology Officer of Sadra Medical prior to its acquisition by Boston Scientific Corporation and remained with Boston as a Vice President after the acquisition. Prior to Sadra, Robert co-founded and served as President, CEO and Director at Ample Medical. Previously, he held positions of increasing responsibility at Satiety, IsoStent and Devices for Vascular Intervention.